An international group of cancer researchers led by the National Cancer Research Institute’s (NCRI’s) Cellular Molecular Pathology Initiative (CMPath) has published guidance to address the variability in how pathology (the […]
Lessons learned from a new survey about what motivates and retains patients in rare disease trials could have much wider applications in other clinical trials, according to those who conducted […]
“The FDA doesn’t call to ask if it’s a good time for an inspection,” Neala Lane, Associate Director, Quality Improvement Office at Indiana University told attendees of ACRP’s Virtual […]
Moffitt Cancer Center is among more than 75 sites participating in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community […]
Clinical Researcher—September 2021 (Volume 35, Issue 7) EXECUTIVE DIRECTOR’S MESSAGE Susan P. Landis, Executive Director of ACRP (susan.landis@acrpnet.org) We’ve been talking about you, and I hope your ears […]